Induction_NN
of_IN
a_DT
functional_JJ
vitamin_NN
D_NN
receptor_NN
in_IN
all-trans-retinoic_JJ
acid-induced_JJ
monocytic_JJ
differentiation_NN
of_IN
M2-type_JJ
leukemic_JJ
blast_NN
cells_NNS
._.

Different_JJ
types_NNS
of_IN
acute_JJ
myeloid_JJ
leukemia_NN
blast_NN
cells_NNS
were_VBD
induced_VBN
to_TO
differentiate_VB
in_FW
vitro_FW
with_IN
all-trans-retinoic_JJ
acid_NN
-LRB-_-LRB-
ATRA_NN
-RRB-_-RRB-
and_CC
vitamin_NN
D3_NN
-LRB-_-LRB-
VD_NN
-RRB-_-RRB-
._.

M0\/M1_NN
leukemic_JJ
cells_NNS
are_VBP
not_RB
sensitive_JJ
to_TO
differentiating_VBG
agents_NNS
,_,
whereas_IN
M3_NN
leukemic_JJ
cells_NNS
are_VBP
induced_VBN
to_TO
undergo_VB
granulocytic_JJ
differentiation_NN
after_IN
ATRA_NN
treatment_NN
but_CC
are_VBP
not_RB
sensitive_JJ
to_TO
VD_NN
._.

M2_NN
leukemic_JJ
blast_NN
cells_NNS
behave_VBP
differently_RB
because_IN
they_PRP
undergo_VBP
monocytic_JJ
differentiation_NN
with_IN
both_DT
the_DT
differentiation_NN
inducers_NNS
._.

To_TO
gain_VB
some_DT
insight_NN
into_IN
the_DT
maturation_NN
of_IN
M2-type_JJ
leukemic_JJ
cells_NNS
,_,
we_PRP
studied_VBD
the_DT
molecular_JJ
mechanisms_NNS
underlying_VBG
monocytic_JJ
differentiation_NN
induced_VBN
by_IN
ATRA_NN
and_CC
VD_NN
in_IN
spontaneous_JJ
M2_NN
blast_NN
cells_NNS
as_RB
well_RB
as_IN
in_IN
Kasumi-1_NN
cells_NNS
-LRB-_-LRB-
an_DT
acute_JJ
myeloid_JJ
leukemia_NN
M2-type_JJ
cell_NN
line_NN
-RRB-_-RRB-
._.

Our_PRP$
results_NNS
indicate_VBP
that_IN
ATRA_NN
as_RB
well_RB
as_IN
VD_NN
efficiently_RB
increases_VBZ
the_DT
nuclear_JJ
abundance_NN
of_IN
VD_NN
receptor_NN
-LRB-_-LRB-
VDR_NN
-RRB-_-RRB-
and_CC
promotes_VBZ
monocytic_JJ
differentiation_NN
._.

VDR_NN
is_VBZ
functionally_RB
active_JJ
in_IN
ATRA-treated_JJ
Kasumi-1_NN
cells_NNS
because_IN
it_PRP
efficiently_RB
heterodimerizes_VBZ
with_IN
retinoid_NN
X_NN
receptor_NN
,_,
binds_VBZ
to_TO
a_DT
DR3-type_JJ
vitamin_NN
D-responsive_JJ
element_NN
,_,
and_CC
activates_VBZ
the_DT
transcription_NN
of_IN
a_DT
vitamin_NN
D-responsive_JJ
element-regulated_JJ
reporter_NN
gene_NN
._.

Consistent_JJ
with_IN
these_DT
findings_NNS
,_,
VD-responsive_JJ
genes_NNS
are_VBP
induced_VBN
by_IN
ATRA_NN
treatment_NN
of_IN
Kasumi-1_NN
cells_NNS
,_,
suggesting_VBG
that_IN
the_DT
genetic_JJ
program_NN
underlying_VBG
monocytic_JJ
differentiation_NN
is_VBZ
activated_VBN
._.

The_DT
molecular_JJ
mechanism_NN
by_IN
which_WDT
ATRA_NN
increases_VBZ
the_DT
nuclear_JJ
abundance_NN
of_IN
a_DT
functional_JJ
VDR_NN
is_VBZ
still_RB
unknown_JJ
,_,
but_CC
our_PRP$
data_NNS
clearly_RB
indicate_VBP
that_IN
the_DT
M2_NN
leukemic_JJ
cell_NN
context_NN
is_VBZ
only_RB
permissive_JJ
of_IN
monocytic_JJ
differentiation_NN
._.

